Status:
COMPLETED
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Facial Wrinkles
Eligibility:
All Genders
30-55 years
Phase:
NA
Brief Summary
A clinical study to investigate the safety and efficacy of Hylaform and Hylaform Plus for correction of facial wrinkles.
Eligibility Criteria
Inclusion
- bilateral nasolabial folds with severity score 3 or 4 on the 6-point grading scale
Exclusion
- pregnant/lactating women
- patients who previously received permanent facial implants or using ovet-the-counter products
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00288470
Start Date
June 1 2002
End Date
August 1 2003
Last Update
March 18 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.